Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
95.35
+3.78 (4.13%)
At close: Jun 26, 2026, 4:00 PM EDT
93.45
-1.90 (-1.99%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Dianthus Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Dianthus Therapeutics stock have an average target of 129.73, with a low estimate of 98 and a high estimate of 200. The average target predicts an increase of 36.06% from the current stock price of 95.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Dianthus Therapeutics stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 15 | 16 | 15 | 15 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Reiterates $135 | Buy | Reiterates | $135 | +41.58% | Jun 17, 2026 |
| Jefferies | Jefferies | Buy Maintains $132 | Buy | Maintains | $132 | +38.44% | Jun 15, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $105 | Buy | Maintains | $105 | +10.12% | Jun 15, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 12, 2026 |
Financial Forecast
Revenue This Year
1.21M
from 2.04M
Decreased by -40.59%
Revenue Next Year
1.59M
from 1.21M
Increased by 31.06%
EPS This Year
-3.93
from -4.20
EPS Next Year
-4.65
from -3.93
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.5M | 6.0M | |
| Avg | 1.2M | 1.6M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.1% | 396.0% | |
| Avg | -40.6% | 31.1% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.44 | -3.69 | |
| Avg | -3.93 | -4.65 | |
| Low | -5.06 | -5.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.